We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Sep 20
RDIF will supply Dr. Reddy's with 100 million doses of potential Covid-19 vaccine Sputnik V, upon receiving the…
16 Sep 20
The new manufacturing facility in Boston is designed to primarily focus on oncology, with plans to expand into…
PharmaceuticalsProtein and Peptide Synthesis and Manufacturing
16 Sep 20
The FDA designation enables development of Jardiance to prevent hospitalisation for heart failure and minimise the risk of…
15 Sep 20
Merck will make an upfront payment of $600m along with a $1bn equity investment by acquiring five million…
15 Sep 20
Dupixent is a human monoclonal antibody developed by Sanofi and Regeneron to inhibit the signalling of interleukin-4 (IL-4)…
14 Sep 20
The deal will benefit Gilead with Trodelvy (sacituzumab govitecan-hziy), an advanced Trop-2 directed antibody-drug conjugate, developed by Immunomedics
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Sep 20
The UK committee has resolved its investigations and recommended the MHRA that Covid-19 vaccine trials in the UK…
11 Sep 20
Janssen filed a supplemental Biologics License Application (sBLA) with the FDA for the approval of subcutaneous formulation of…
11 Sep 20
ENSPRYNG was recently approved by the US Food and Drug Administration (FDA) for adults with anti-aquaporin-4 (AQP4) antibody…
10 Sep 20
Trelegy Ellipta is a combination of three molecules, fluticasone furoate, umeclidinium and vilanterol (FF/UMEC/VI) for once-daily single inhalation